Biopharma

Bruce is currently a Private Equity Associate with Adams Street Partners, a global private markets investment manager with investments in more than 30 countries across five continents. The firm has approximately $65 billion in assets under management across primary, secondary, growth equity, credit, and co-investment strategies.